163 related articles for article (PubMed ID: 20307571)
1. Outcomes of cryptococcal meningitis in antiretroviral naïve and experienced patients in South Africa.
Jarvis JN; Meintjes G; Harrison TS
J Infect; 2010 Jun; 60(6):496-8. PubMed ID: 20307571
[No Abstract] [Full Text] [Related]
2. Cryptococcal Meningitis Presenting as a Complication in HIV-infected Children: A Case Series From Sub-Saharan Africa.
Nyazika TK; Masanganise F; Hagen F; Bwakura-Dangarembizi MF; Ticklay IM; Robertson VJ
Pediatr Infect Dis J; 2016 Sep; 35(9):979-80. PubMed ID: 27187754
[TBL] [Abstract][Full Text] [Related]
3. Advanced Human Immunodeficiency Virus Disease in Botswana Following Successful Antiretroviral Therapy Rollout: Incidence of and Temporal Trends in Cryptococcal Meningitis.
Tenforde MW; Mokomane M; Leeme T; Patel RKK; Lekwape N; Ramodimoosi C; Dube B; Williams EA; Mokobela KO; Tawanana E; Pilatwe T; Hurt WJ; Mitchell H; Banda DL; Stone H; Molefi M; Mokgacha K; Phillips H; Mullan PC; Steenhoff AP; Mashalla Y; Mine M; Jarvis JN
Clin Infect Dis; 2017 Sep; 65(5):779-786. PubMed ID: 28505328
[TBL] [Abstract][Full Text] [Related]
4. Cryptococcal meningitis in a tertiary hospital in Pretoria, mortality and risk factors - A retrospective cohort study.
Hiesgen J; Schutte C; Olorunju S; Retief J
Int J STD AIDS; 2017 Apr; 28(5):480-485. PubMed ID: 27255493
[TBL] [Abstract][Full Text] [Related]
5. A pragmatic approach to managing antiretroviral therapy-experienced patients diagnosed with HIV-associated cryptococcal meningitis: impact of antiretroviral therapy adherence and duration.
Alufandika M; Lawrence DS; Boyer-Chammard T; Kanyama C; Ndhlovu CE; Mosepele M; Tugume L; Meya D; Boulware DR; Rhein J; Muzoora C; Youssouf N; Molloy SF; Schutz C; Lortholary O; Meintjes G; Mwandumba HC; Harrison TS; Jarvis JN;
AIDS; 2020 Jul; 34(9):1425-1428. PubMed ID: 32590438
[No Abstract] [Full Text] [Related]
6. Fungal burden, early fungicidal activity, and outcome in cryptococcal meningitis in antiretroviral-naive or antiretroviral-experienced patients treated with amphotericin B or fluconazole.
Bicanic T; Meintjes G; Wood R; Hayes M; Rebe K; Bekker LG; Harrison T
Clin Infect Dis; 2007 Jul; 45(1):76-80. PubMed ID: 17554704
[TBL] [Abstract][Full Text] [Related]
7. Utility of Cryptococcal Antigen Screening and Evolution of Asymptomatic Cryptococcal Antigenemia among HIV-Infected Women Starting Antiretroviral Therapy in Thailand.
Kwan CK; Leelawiwat W; Intalapaporn P; Anekthananon T; Raengsakulrach B; Peters PJ; McNicholl JM; Park BJ; McConnell MS; Weidle PJ
J Int Assoc Provid AIDS Care; 2014; 13(5):434-7. PubMed ID: 24003059
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of screening and treatment of cryptococcal antigenaemia among HIV-infected persons in Soweto, South Africa.
Govender NP; Roy M; Mendes JF; Zulu TG; Chiller TM; Karstaedt AS
HIV Med; 2015 Sep; 16(8):468-76. PubMed ID: 25689352
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of Asymptomatic Cryptococcal Antigenemia and Association with Follow-up Risk of Cryptococcal Meningitis and Mortality among HIV Infected Patients in North West India: A Prospective Cohort Study.
Bhati R; Pramendra S; Sejoo B; Kumar D; Bohra GK; Meena DS; Verma D; Midha NK
Curr HIV Res; 2021; 19(1):35-39. PubMed ID: 32860359
[TBL] [Abstract][Full Text] [Related]
10. Long-term follow-up and survival of antiretroviral-naive patients with cryptococcal meningitis in the pre-antiretroviral therapy era, Gauteng Province, South Africa.
Park BJ; Shetty S; Ahlquist A; Greenbaum A; Miller JL; Motsi A; McCarthy K; Govender N;
Int J STD AIDS; 2011 Apr; 22(4):199-203. PubMed ID: 21515751
[TBL] [Abstract][Full Text] [Related]
11. Preventing deaths from cryptococcal meningitis: from bench to bedside.
Roy M; Chiller T
Expert Rev Anti Infect Ther; 2011 Sep; 9(9):715-7. PubMed ID: 21905781
[TBL] [Abstract][Full Text] [Related]
12. Cryptococcal antigenemia is associated with meningitis or death in HIV-infected adults with CD4 100-200 cells/mm
Wykowski J; Galagan SR; Govere S; Wallis CL; Moosa MY; Celum C; Drain PK
BMC Infect Dis; 2020 Jan; 20(1):61. PubMed ID: 31959112
[TBL] [Abstract][Full Text] [Related]
13. Implementation and Operational Research: Evaluation of a Public-Sector, Provider-Initiated Cryptococcal Antigen Screening and Treatment Program, Western Cape, South Africa.
Vallabhaneni S; Longley N; Smith M; Smith R; Osler M; Kelly N; Cross A; Boulle A; Meintjes G; Govender NP
J Acquir Immune Defic Syndr; 2016 Jun; 72(2):e37-e42. PubMed ID: 26926942
[TBL] [Abstract][Full Text] [Related]
14. Antiretroviral roll-out, antifungal roll-back: access to treatment for cryptococcal meningitis.
Bicanic T; Wood R; Bekker LG; Darder M; Meintjes G; Harrison TS
Lancet Infect Dis; 2005 Sep; 5(9):530-1. PubMed ID: 16122672
[No Abstract] [Full Text] [Related]
15. Decreasing incidence of cryptococcal meningitis in West Africa in the era of highly active antiretroviral therapy.
Bamba S; Lortholary O; Sawadogo A; Millogo A; Guiguemdé RT; Bretagne S
AIDS; 2012 May; 26(8):1039-41. PubMed ID: 22552479
[TBL] [Abstract][Full Text] [Related]
16. Cryptococcal meningitis in HIV-infected patients: a longitudinal study in Cambodia.
Espié E; Pinoges L; Balkan S; Chanchhaya N; Molfino L; Narom P; Pujades-Rodríguez M
Trop Med Int Health; 2010 Nov; 15(11):1375-81. PubMed ID: 20868415
[TBL] [Abstract][Full Text] [Related]
17. Asymptomatic cryptococcal antigen prevalence detected by lateral flow assay in hospitalised HIV-infected patients in São Paulo, Brazil.
Vidal JE; Toniolo C; Paulino A; Colombo A; Dos Anjos Martins M; da Silva Meira C; Pereira-Chioccola VL; Figueiredo-Mello C; Barros T; Duarte J; Fonseca F; Alves Cunha M; Mendes C; Ribero T; Dos Santos Lazera M; Rajasingham R; Boulware DR
Trop Med Int Health; 2016 Dec; 21(12):1539-1544. PubMed ID: 27699970
[TBL] [Abstract][Full Text] [Related]
18. Testing but not treating: missed opportunities and lost lives in the South African antiretroviral therapy programme.
Jarvis JN; Meintjes G; Wood R; Harrison TS
AIDS; 2010 May; 24(8):1233-5. PubMed ID: 20421745
[No Abstract] [Full Text] [Related]
19. Routine cryptococcal antigen screening for HIV-infected patients with low CD4+ T-lymphocyte counts--time to implement in South Africa?
Jarvis JN; Harrison TS; Govender N; Lawn SD; Longley N; Bicanic T; Maartens G; Venter F; Bekker LG; Wood R; Meintjes G
S Afr Med J; 2011 Apr; 101(4):232-4. PubMed ID: 21786721
[No Abstract] [Full Text] [Related]
20. Timing of antiretroviral therapy after diagnosis of cryptococcal meningitis.
Boulware DR; Meya DB; Muzoora C; Rolfes MA; Huppler Hullsiek K; Musubire A; Taseera K; Nabeta HW; Schutz C; Williams DA; Rajasingham R; Rhein J; Thienemann F; Lo MW; Nielsen K; Bergemann TL; Kambugu A; Manabe YC; Janoff EN; Bohjanen PR; Meintjes G;
N Engl J Med; 2014 Jun; 370(26):2487-98. PubMed ID: 24963568
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
